# Antifungal Susceptibility Trends Among Filamentous Fungi: An Epidemiological Evaluation on Aspergillus spp., Fusarium spp., and Scedosporium spp. from Southern Italy

**Authors:** Maddalena Calvo, Marta Caccamo, Dalila Maria Cammarata, Laura Trovato

PMC · DOI: 10.3390/antibiotics15020146 · Antibiotics · 2026-02-02

## TL;DR

This study examines antifungal resistance trends in filamentous fungi from Southern Italy, revealing rising resistance to key drugs.

## Contribution

The study provides new epidemiological data on antifungal susceptibility trends in Aspergillus, Fusarium, and Scedosporium species in Southern Italy.

## Key findings

- Aspergillus fumigatus showed increased resistance to amphotericin B with 9.1% reduced susceptibility.
- Lomentospora prolificans and Scedosporium apiospermum demonstrated multidrug resistance across tested antifungals.
- Fusarium species exhibited variable susceptibility with higher MICs for azoles and amphotericin B.

## Abstract

Background/Objectives: Antifungal resistance among filamentous fungi is an increasing global concern with significant implications for clinical management. Herein, we propose a study aiming to investigate in vitro susceptibility patterns and epidemiology of filamentous fungi in Southern Italy, focusing on MIC distributions and resistance trends. Methods: We reported susceptibility results from Aspergillus spp., Fusarium spp., and Scedosporium/Lomentospora spp. clinical isolates, which underwent azoles, echinocandins, and amphotericin B in vitro testing. Results: Aspergillus fumigatus was the most frequently isolated species, showing an alarming increase in reduced susceptibility to amphotericin B (9.1%). The highest MIC ranges for this antifungal drug emerged in the case of A. fumigatus (1–4 mg/L) and A. terreus (2–8 mg/L), while A. flavus (0.5–4 mg/L) and A. niger (0.25–4 mg/L) showed lower values. As regarding azoles, all the Aspergillus spp. strains exhibited variable MIC values, reporting a 0.06–16 mg/L MIC range for itraconazole, 0.125–1 mg/L for voriconazole, and 0.03–1 mg/L for posaconazole. Fusarium solani exhibited high MICs for azoles (8 mg/L) and amphotericin B (2–4 mg/L), while F. oxysporum and F. proliferatum showed lower MICs (0.25–2 mg/L for amphotericin B and a MIC range of 0.5–8 mg/L for posaconazole). Lomentospora prolificans and Scedosporium apiospermum demonstrated multidrug resistance across all tested antifungals, reporting MIC ranges of 4–8 mg/L for amphotericin B, 0.25–16 mg/L for posaconazole, 0.25–8 mg/L for voriconazole, and 0.125–8 for itraconazole. Conclusions: Our data highlight the critical emergence of reduced antifungal susceptibility among filamentous fungi in Southern Italy, underlining the importance of epidemiological surveillance, precise species identification, and optimized susceptibility testing in the case of mould etiology for invasive fungal infections.

## Linked entities

- **Chemicals:** amphotericin B (PubChem CID 1972), itraconazole (PubChem CID 55283), voriconazole (PubChem CID 71616), posaconazole (PubChem CID 468595), azoles (PubChem CID 699591)
- **Species:** Aspergillus fumigatus (taxon 746128), Aspergillus terreus (taxon 33178), Aspergillus flavus (taxon 5059), Aspergillus niger (taxon 5061), Fusarium solani (taxon 169388), Fusarium oxysporum (taxon 5507), Fusarium proliferatum (taxon 948311), Lomentospora prolificans (taxon 41688), Scedosporium apiospermum (taxon 563466)

## Full-text entities

- **Diseases:** infection (MESH:D007239), immunological impairments (MESH:D007154), fusariosis (MESH:D060585), keratitis (MESH:D007634), neutropenia (MESH:D009503), leukemia (MESH:D007938), invasive fungal infection (MESH:D000072742), Aspergillosis (MESH:D001228), Mycoses (MESH:D009181), bloodstream infections (MESH:D018805), infectious disease (MESH:D003141), IPA (MESH:D055744), endocarditis (MESH:D004696), osteomyelitis (MESH:D010019), Cancer (MESH:D009369), cystic fibrosis (MESH:D003550), injury to (MESH:D014947), respiratory infection (MESH:D012141), critically ill (MESH:D016638), pulmonary aspergillosis (MESH:D055732), respiratory diseases (MESH:D012140)
- **Chemicals:** HCCA (MESH:C007175), amphotericin B (MESH:D000666), isavuconazole (MESH:C508735), ergosterol (MESH:D004875), FZ (-), cycloheximide (MESH:D003513), caspofungin (MESH:D000077336), glucose (MESH:D005947), CAS (MESH:D002118), triazole (MESH:D014230), fluconazole (MESH:D015725), itraconazole (MESH:D017964), acetonitrile (MESH:C032159), azole (MESH:D001393), formic acid (MESH:C030544), Echinocandin (MESH:D054714), ethanol (MESH:D000431), voriconazole (MESH:D065819), posaconazole (MESH:C101425), rezafungin (MESH:C000629634)
- **Species:** Fusarium keratoplasticum (species) [taxon 1328300], Homo sapiens (human, species) [taxon 9606], Scedosporium boydii (species) [taxon 5597], Aspergillus flavus (species) [taxon 5059], Scedosporium apiospermum (species) [taxon 563466], Fusarium oxysporum (species) [taxon 5507], Fusarium proliferatum (species) [taxon 948311], Aspergillus niger (species) [taxon 5061], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Aspergillus fumigatus (species) [taxon 746128], Lomentospora prolificans (species) [taxon 41688], Fusarium solani (species) [taxon 169388], A. flavus [taxon 315677], Fungi (kingdom) [taxon 4751], Aspergillus terreus (species) [taxon 33178]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937208/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12937208/full.md

## References

41 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937208/full.md

---
Source: https://tomesphere.com/paper/PMC12937208